NCI is soliciting grant applications for the competing continuation of previously funded Phase II SBIR/STTR grants that propose to continue the process of developing products for commercialization that ultimately require: 1) approval of a Federal regulatory agency and 2) clinical evaluation up to "proof of principle" demonstration, generally only through a Phase II clinical trial. Such products include, but are not limited to: radioligands, biomarkers, medical implants or devices, imaging protocols proposed for clinical use, new software for instrument performance, etc.

• Release Date: January 5, 2004
• Letter of Intent Receipt Date(s): March 1, July 1, November 1
• Application Receipt Date(s): April 1, August 1, December 1 (standard SBIR/STTR deadlines)
• Contact: Contact: Barbara Y. Croft, Ph.D. (bc129b@nih.gov) at 301-496-9531

See full description in NIH Guide: PA-04-047

What is SBIR?
What is STTR?